Delivery Order SPE2DB22D2108-SPE2DB26FU2PG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,151.91 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 MCG vaginal inserts (8-count package). This is a firm fixed-price delivery order with no set-aside designation, issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,004.48 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 microgram vaginal inserts (18-count package) on November 6, 2025, with completion expected by November 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,093.79 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.03 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of November 12, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $1,748.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (8-count packaging). The delivery order, which concludes on September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,054.25 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and runs through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $2,115.12 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on September 15, 2025, for Yuvafem 10 mcg vaginal inserts (18-count package). This is a firm fixed-price delivery order with a ceiling value of $1,616.52, with an ultimate completion date of September 16, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,502.24 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (8-count units). This firm fixed-price, non-set-aside delivery order was awarded on August 28, 2025, with an ultimate completion date of August 29, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,563.86 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB26FU2PGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,314.68 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (8-count package) under a firm fixed-price contract. The award was made on October 21, 2025, with an ultimate completion date of October 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a substantial prime indefinite delivery vehicle valued at $999,999,999.00 with DLA Troop Support Medical (contract SPE2DX) running through December 2026. This comprehensive global pharmaceutical support contract enables the company to supply a wide range of medications, vaccines, and medical supplies to support military and veteran healthcare systems. The current delivery order for Yuvafem represents a routine pharmaceutical procurement under this framework, serving the federal healthcare supply chain that supports the Defense Health Agency, U.S. Coast Guard, and other government medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/21/25 |